October 15, 2026
According to Payal Rabde, who specializes in targeted therapies, HER2-targeted therapies, and precision oncology, biomarker-based diagnostics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong g...
February 11, 2026
Based on our market forecasts, the metastatic pancreatic cancer treatment market was valued at USD 3.68 billion in 2025 and is projected to grow from USD 3.91 billion in 2026 to approximately USD 6.75 billion by 2035, registering a CAGR of 6.25% duri...
October 01, 2026
The global breast cancer liquid biopsy market size was estimated at USD 229.6 million in 2025 and is predicted to increase from USD 263.58 million in 2026 to approximately USD 912.83 million by 2035, expanding at a CAGR of 14.8% from 2026 to 2035. Ou...
April 21, 2026
Market insights predict, the breast cancer screening tests industry is expected to grow from USD 4.44 billion in 2024 to USD 8.77 billion by 2034, driven by a CAGR of 7.04%. The breast cancer screening tests market is growing due to its major applica...
August 21, 2026
According to Payal Rabde, who specializes in silicone and saline implants used for breast augmentation and reconstruction, and products available in various shapes, sizes, profiles, and surface designs, with 4+ years of experience in market research ...
October 15, 2026
The ESR1-targeted breast cancer therapy market is projected to reach around US$ 4.17 billion by 2035, expanding at a CAGR of 21.8% between 2026 and 2036. The ESR1-targeted breast cancer therapy market report examines market size, segmentation, compet...
April 21, 2026
Market insights predict the global breast pump industry will increase from USD 3.23 billion in 2024 to USD 7.58 billion by 2034, achieving a CAGR of 8.63%. In 2024, North America led the global breast pump market with a 54% share, while Europe is set...
October 15, 2026
The report analyses the breast biopsy devices market based on market key takeaways, market overview, market trends & future outlook, segmental insights, regional insights, top vendors, and recent developments. The analysis was led by Payal Rabde,...
April 21, 2026
According to market projections, the South Korea breast pump sector is expected to grow from USD 20.41 million in 2024 to USD 41.66 million by 2034, reflecting a CAGR of 7.44%. In 2024, closed-system breast pumps led the South Korea market and will g...
September 29, 2026
According to forecasts, the global AI in breast imaging market will grow from USD 556.16 million in 2026 to USD 744.90 million by 2035, with an expected CAGR of 3.30%. AI in breast imaging refers to the use of artificial intelligence to assist in det...
May 28, 2026
U.S. Breast Biopsy Devices Market (By Product: Needle-based Biopsy, Localized Wires, Guidance Systems, Biopsy Tables; By Technology: Vacuum-Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration, Image-Guided Biopsy; By Guidance Technique: Ultra...
August 07, 2026
According to Payal Rabde, who specializes in medical devices, cancer diagnostics, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in ...
September 01, 2026
According to Payal Rabde, who specializes in 3D breast imaging, advanced breast cancer screening, lesion detection, diagnostic mammography, and early identification of breast abnormalities, with 4+ years of experience in market research and industry ...
February 24, 2026
According to market projections, the global cancer biopsy market, valued at USD 36.61 billion in 2025, is anticipated to reach USD 205.72 billion by 2035, growing at a CAGR of 18.84% over the next decade. Increasing advancements in biopsy technolog...
August 12, 2026
According to Payal Rabde, who specializes in medicines that prevent, reduce, and manage side effects of cancer and its treatments, helping improve patient comfort, treatment adherence, and overall quality of life, with 4+ years of experience in marke...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Cervical cancer is caused by HPV infections and diagnosed through tests like Pap tests, HPV tests, biopsies, and imaging. Regular screenings and advancements in diagnostic techniques are driving market growth. Initiatives like the WHO’s Global ...
April 21, 2026
Based on market forecasts, the bladder cancer vaccines market was valued at USD 370.2 million in 2025 and is expected to grow from USD 456.83 million in 2026 to approximately USD 3,031.01 million by 2035, registering a strong CAGR of 23.4% during 202...
April 21, 2026
Based on market forecasts, the global next generation cancer diagnostics market, projected at USD 19.20 billion in 2025, is expected to reach USD 41.64 billion by 2035, growing at a CAGR of 8.05% over the forecast period. The market is driven by the ...
August 21, 2026
According to our market projections, the brain cancer sector is expected to grow from USD 3.4 billion in 2026 to USD 8.06 billion by 2035, reflecting a CAGR of 10.07%. Brain Cancer Market (By Product/Solution Type: Therapeutic Treatments, Diagnostic ...
October 07, 2026
The report analyses the India home-based cancer care market based on market overview, market size & growth, market segmentation, demand landscape, competitive landscape, key ecosystem players, value chain analysis, customer analysis, market drive...
July 16, 2026
According to our projections, the global lung cancer trial market, valued at USD 4.34 billion in 2025, is anticipated to reach USD 9.76 billion by 2035, growing at a CAGR of 8.45% over the next decade. The lung cancer trial market is growing due to i...
April 21, 2026
According to market projections, the cancer stem cells sector is expected to grow from USD 3.2 billion in 2024 to USD 8.04 billion by 2034, reflecting a CAGR of 9.64%. Stem cell-based therapies are highly useful in providing high-quality treatment, d...
October 13, 2026
According to Payal Rabde, who specializes in diagnosis and management, nutritional support and metabolic therapies, pharmacological treatments, and supportive and palliative care, digital pathology image analysis, AI-powered cancer diagnosis, and bio...
April 21, 2026
According to market projections, the NUT midline carcinoma treatment sector is expected to grow from USD 23.92 billion in 2025 to USD 68.89 billion by 2035, reflecting a CAGR of 11.15%. The growth of the market is driven by innovations in targeted th...
August 31, 2026
According to Payal Rabde, who specializes in the identification of unique molecular traits, genetic changes in cancer patients, and biological signals to detect, diagnose, and guide the patient for the treatment of cancer, with 4+ years of experience...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
July 31, 2026
Market insights predict the global pancreatic cancer industry will increase from USD 3.42 billion in 2026 to USD 10.87 billion by 2035, achieving a CAGR of 13.7%. Pancreatic cancer is a deadly disease that starts in the pancreas, an organ that helps ...
September 24, 2026
Market insights predict the global cancer diagnostics industry will increase from USD 116.42 billion in 2025 to USD 211.85 billion by 2035, achieving a CAGR of 6.17%. The market is growing due to the rising global cancer incidence and increasing awar...
April 21, 2026
According to market projections, the global cancer biologics market, valued at USD 110.91 billion in 2024, is anticipated to reach USD 232.02 billion by 2034, growing at a CAGR of 7.66% over the next decade. Rising cancer research is anticipated...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispec...
April 21, 2026
Market insights predict the global cervical cancer treatment industry will increase from USD 8.65 billion in 2024 to USD 14.68 billion by 2034, achieving a CAGR of 5.44%. In 2024, North America led the cervical cancer treatment market, with Europe se...
January 20, 2026
Projections indicate the global chemotherapy market will increase from USD 10.29 billion in 2025 to USD 21.33 billion by 2035, experiencing a CAGR of 7.56% over the next 10 years. In 2024, North America led the global chemotherapy market with a 45% s...
September 15, 2026
According to Payal Rabde, who specializes in pharmaceuticals, clinical trials, healthcare services, and biotechnology, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in t...
August 12, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
September 11, 2026
According to Payal Rabde, who specializes in disease diagnostics, healthcare services, and oncology research, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the AI in ...
April 24, 2026
CAR T-Cell Neurotoxicity Detection Market (By Detection Method: Biomarker-based Detection, AI-based & Wearable Monitoring Neuroimaging, Electrophysiology, Cognitive & Behavioral Assessment Tools; By Product/Service Type: Diagnostic Kits &...
April 21, 2026
According to forecasts, the Japan cell cancer vaccine market will grow from USD 320.6 million in 2024 to USD 576.4 million by 2034, with an expected CAGR of 6.04%. The Japan cell cancer vaccine market is expanding due to rising incidences of cancer a...
April 21, 2026
According to market projections, the cancer vaccines sector is expected to grow from USD 11.38 billion in 2024 to USD 33.61 billion by 2034, reflecting a CAGR of 11.44%. The increasing prevalence of cancer, research and development and continuous eff...
September 04, 2026
According to Payal Rabde, who specializes in technologies and tests used to detect, identify, and monitor thyroid cancer, including imaging, biopsy, molecular testing, and laboratory-based diagnostics, with 4+ years of experience in market research a...
October 15, 2026
The report analyses the personalized cancer vaccine market based on market key takeaways, market overview, market trends & future outlook, segmental insights, regional insights, top vendors, and recent developments. The analysis was led by Payal ...
October 12, 2026
According to market projections, the gene therapies for cancer treatment sector is expected to grow from USD 8.28 billion in 2024 to USD 238.77 billion by 2034, reflecting a CAGR of 39.94%. The rising prevalence of cancer and the growing demand for p...
February 24, 2026
Based on our market forecasts, the pancreatic cancer precision medicine sector will expand from USD 815.63 million in 2025 to USD 4739.26 million by 2035, experiencing a CAGR of 19.24%....
April 21, 2026
Projections indicate that, U.S. cell therapy industry is projected to rise from USD 6.62 billion in 2024 to USD 46.26 billion by 2034, reflecting a CAGR of 21.46% over the next decade. The increasing prevalence of chronic conditions is driving the gr...
October 12, 2026
According to Payal Rabde, who specializes in targeted therapies for head and neck cancers, immunotherapy treatments, including immune checkpoint inhibitors, and chemotherapy drugs and combination therapies, with 4+ years of experience in market resea...
July 20, 2026
According to Payal Rabde, who specializes in periodontal tissue regeneration, bone grafting, alveolar bone regeneration, and guided bone regeneration, with 4+ years of experience in market research and industry analysis, extensive research indicates ...
January 16, 2026
According to market projections, the global hyperthermia cancer treatment market, valued at USD 210.54 million in 2025, is anticipated to reach USD 380.63 million by 2035, growing at a CAGR of 6.1% over the next decade. The rising incidences of cance...
March 25, 2026
U.S. CAR T-Cell Therapies Market (By Drug Type: Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others; By Indication: Lymphoma, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Others; By E...
June 03, 2026
U.S. Non-Invasive Cancer Diagnostics Market (By Product Type: Instruments, Reagents & Kits, Software & Services; By Therapeutic Area: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Liquid Biopsy, Imaging Technology, Microa...
April 21, 2026
Based on market forecasts, the global whole genome sequencing market, projected at USD 2.15 billion in 2024, is expected to reach USD 15.96 billion by 2034, growing at a CAGR of 22.2% over the forecast period. The market is growing due to increasing ...
April 21, 2026
Based on market forecasts, the global advanced liver cancer market, projected at USD 2.65 billion in 2024, is expected to reach USD 8.2 billion by 2034, growing at a CAGR of 11.94% over the forecast period. Emergence of diverse severe liver issues ...
September 29, 2026
Market insights predict, the non-small cell lung cancer therapeutics industry is expected to grow from USD 24.24 billion in 2025 to USD 71.2 billion by 2034, driven by a CAGR of 12.74%. The non-small cell lung cancer therapeutics market is expanding ...
April 21, 2026
Based on market forecasts, the circulating tumor cells sector will expand from USD 13.06 billion in 2024 to USD 46.9 billion by 2034, experiencing a CAGR of 13.64%. The growing prevalence of cancer drives the market’s growth....
April 21, 2026
Expansion of healthcare facilities, especially in emerging economies, is improving access to advanced cancer treatments, further supporting market expansion. North America has a robust healthcare system with significant spending on advanced treatme...
April 21, 2026
According to market projections, the CDK4/6 inhibitors sector is expected to grow from USD 11.38 billion in 2024 to USD 46.96 billion by 2034, reflecting a CAGR of 15.34%. The rising prevalence of cancer and growing research and development activit...
April 21, 2026
According to market projections, the blood product sector is expected to grow from USD 39.96 billion in 2025 to USD 62.65 billion by 2035, reflecting a CAGR of 4.6%, driven by rising demand in surgeries, cancer care, and trauma cases. North America l...
October 05, 2026
The report analyses the APAC multi-cancer early detection market based on market key takeaways, market overview, segmental insight, regional insights, TAM, SAM, SOM, consumer behavior & buyer intelligence analysis, and strategic key takeaways. Th...
April 21, 2026
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
+1 9197 992 333
+91 93077 85324
